The Government of India has prohibited exports of injection Remdesivir and Active Pharmaceutical Ingredients of Remdesivir amid the rising COVID-19 cases in India.
- The Central Government has also advised the States that the extant has been developed after many interactions by Committee of Experts, and is the guiding document for treatment of Covid-19 patients. In the National Clinical Management Protocol for COVID-19, Remdesivir is listed as an Investigational Therapy, where informed and shared decision making is essential, besides taking note of contra indications mentioned in the detailed guidelines.
- Seven Indian companies are producing injection Remdesivir under voluntary licensing agreement with Gilead Sciences, USA.
- Remdesivir is an injectable anti-viral that aims to prevent replication of the virus. It was manufactured in 2014 to treat Ebola, and has since been used to treat SARS and MERS.
- Remdesivir (Veklury) was the first drug approved by the US-FDA for treating the SARS-CoV-2 virus.
